Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS` EQUITY (UNAUDITED) - 9 months ended Jul. 31, 2017 - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Oct. 31, 2016 $ 14,000 $ 87,524 $ 152,051,144 $ (151,165,193) $ 987,475
Balance (in Shares) at Oct. 31, 2016 140 8,752,387      
Stock option compensation to employees and directors     932,773   932,773
Common stock issued upon exercise of stock options   $ 22 5,643   5,665
Common stock issued upon exercise of stock options (in Shares)   2,200      
Common stock issued to consultants   $ 35 17,776   17,811
Common stock issued to consultants (in Shares)   3,463      
Redemption of convertible preferred stock (Note 7) $ (14,000)   (3,486,000)   (3,500,000)
Redemption of convertible preferred stock (Note 7) (in Shares) (140)        
Common stock issued to repay patent acquisition obligation (Note 6)   $ 9,476 2,842,818   2,852,294
Common stock issued to repay patent acquisition obligation (Note 6) (in Shares)   947,606      
Common stock issued in shareholder rights offering   $ 19,892 4,183,410   4,203,302
Common stock issued in shareholder rights offering (in Shares)   1,989,207      
Common stock issued in public offering   $ 34,253 3,177,532   3,211,785
Common stock issued in public offering (in Shares)   3,425,376      
Net loss       (3,223,171) (3,223,171)
Balance at Jul. 31, 2017   $ 151,202 $ 159,725,096 $ (154,388,364) $ 5,487,934
Balance (in Shares) at Jul. 31, 2017   15,120,239